Cargando…

Development and validation of a novel miRNA classifier as a prognostic signature for stage II/III colorectal cancer

BACKGROUND: The TNM staging remains the gold standard for determining the prognosis of patients with colorectal cancer (CRC), which is inadequate at identifying the subset of high-risk stage II and III patients that have a high potential of developing tumor recurrence and may experience death. Emerg...

Descripción completa

Detalles Bibliográficos
Autores principales:	Feng, Junlan, Wei, Qing, Yang, Muqing, Wang, Xiaodong, Liu, Bin, Li, Jiyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246165/ https://www.ncbi.nlm.nih.gov/pubmed/34268360 http://dx.doi.org/10.21037/atm-20-1751

Ejemplares similares

Serum miRNA expression profile as a prognostic biomarker of stage II/III colorectal adenocarcinoma
por: Li, Jialu, et al.
Publicado: (2015)

Novel evidence for oncogenic piRNA‐823 as a promising prognostic biomarker and a potential therapeutic target in colorectal cancer
por: Feng, Junlan, et al.
Publicado: (2020)

Clinical value of integrated-signature miRNAs in colorectal cancer: miRNA expression profiling analysis and experimental validation
por: Chen, XiangJian, et al.
Publicado: (2015)

Development and validation of a collagen signature to predict the prognosis of patients with stage II/III colorectal cancer
por: Dong, Shumin, et al.
Publicado: (2023)

Identification and validation of a miRNA-related expression signature for tumor mutational burden in colorectal cancer
por: Xu, Lijun, et al.
Publicado: (2021)

Validation of miRNA prognostic significance in stage II colorectal cancer: A protocol for systematic review and meta-analysis of observational clinical studies
por: Sabarimurugan, Shanthi, et al.
Publicado: (2019)

Development and Validation of a 6-miRNA Prognostic Signature in Spinal Chordoma
por: Huang, Wei, et al.
Publicado: (2020)

The development and validation of a CT-based radiomics signature for the preoperative discrimination of stage I-II and stage III-IV colorectal cancer
por: Liang, Cuishan, et al.
Publicado: (2016)

Prognostic Factors Influencing Survival in Stage II and Stage III Colorectal Cancer Patients
por: Alkader, Mohammad S, et al.
Publicado: (2023)

Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm
por: Choi, Yoon Young, et al.
Publicado: (2018)

KCNQ1 and lymphovascular invasion are key features in a prognostic classifier for stage II and III colon cancer
por: Uil, Sjoerd H., et al.
Publicado: (2022)

Development and Validation of a 15-gene Expression Signature with Superior Prognostic Ability in Stage II Colorectal Cancer
por: Rokavec, Matjaz, et al.
Publicado: (2023)

miRNA Signature in Early-stage Mycosis Fungoides
por: SØRENSEN, Sissel T., et al.
Publicado: (2022)

ColoFinder: a prognostic 9-gene signature improves prognosis for 871 stage II and III colorectal cancer patients
por: Shi, Mingguang, et al.
Publicado: (2016)

Development of a miRNA‐based classifier for detection of colorectal cancer molecular subtypes
por: Adam, Ronja S., et al.
Publicado: (2022)

Novel miRNA signature for predicting the stage of hepatocellular carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2020)

Exploration and validation of radiomics signature as an independent prognostic biomarker in stage III-IVb nasopharyngeal carcinoma
por: Ouyang, Fu-Sheng, et al.
Publicado: (2017)

Prognostic Factors for Post-Recurrence Survival in Stage II and III Colorectal Carcinoma Patients
por: Nikolic, Neda, et al.
Publicado: (2021)

Development and validation of prognostic nomograms based on De Ritis ratio and clinicopathological features for patients with stage II/III colorectal cancer
por: Fu, Jinming, et al.
Publicado: (2023)

Integrated Analysis of miRNA and mRNA Endorses a Twenty miRNAs Signature for Colorectal Carcinoma
por: Angius, Andrea, et al.
Publicado: (2019)

Establishing a three-miRNA signature as a prognostic model for colorectal cancer through bioinformatics analysis
por: Wang, Yiming, et al.
Publicado: (2021)

Establishment and experimental validation of an immune miRNA signature for assessing prognosis and immune landscape of patients with colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

A novel 9-gene signature for the prediction of postoperative recurrence in stage II/III colorectal cancer
por: Xin, Cheng, et al.
Publicado: (2023)

Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
por: Liu, Zaoqu, et al.
Publicado: (2021)

Identifying a miRNA signature for predicting the stage of breast cancer
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2018)

Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach
por: Qi, Yumei, et al.
Publicado: (2020)

Identification of a sixteen-microRNA signature as prognostic biomarker for stage II and III colon cancer
por: Jacob, Havjin, et al.
Publicado: (2017)

Four-miRNA signature as a prognostic tool for lung adenocarcinoma
por: Lin, Yan, et al.
Publicado: (2017)

Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer
por: Jayaraman, Muralidharan, et al.
Publicado: (2017)

Development of a 4-miRNA prognostic signature for endometrial cancer
por: Huang, Jiazhen, et al.
Publicado: (2022)

Development and validation of an immunity-related classifier of nine chemokines for predicting recurrence in stage I–III patients with colorectal cancer after operation
por: Xu, Guozeng, et al.
Publicado: (2018)

Apoptosome-dependent caspase activation proteins as prognostic markers in Stage II and III colorectal cancer
por: Hector, S, et al.
Publicado: (2012)

HLA-G as a prognostic marker in stage II/III colorectal cancer: not quite there yet
por: Gambella, Alessandro, et al.
Publicado: (2022)

Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis
por: Tang, Kun, et al.
Publicado: (2015)

Prognostic value of the lymph node ratio in stage III colorectal cancer
por: Ren, Jing-Qing, et al.
Publicado: (2012)

Non-Coding RNAs as Prognostic Biomarkers: A miRNA Signature Specific for Aggressive Early-Stage Lung Adenocarcinomas
por: Dama, Elisa, et al.
Publicado: (2020)

Prediction of disease-related miRNAs by voting with multiple classifiers
por: Gu, Changlong, et al.
Publicado: (2023)

Correlation between immune signature and high‐density lipoprotein cholesterol level in stage II/III colorectal cancer
por: Wang, Yun, et al.
Publicado: (2019)

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
por: Mensah, Mavis, et al.
Publicado: (2017)

A Novel Saliva-Based miRNA Signature for Colorectal Cancer Diagnosis
por: Rapado-González, Óscar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ivjllic63bv3oi9lbk8iio04eu